GeneriCo, LLC Comple
GeneriCo, LLC Completes Transaction
July 17, 2018 09:49 ET | GeneriCo, LLC
ST. LOUIS, July 17, 2018 (GLOBE NEWSWIRE) -- GeneriCo, LLC (GeneriCo), a specialty generic drug company, today announced that it completed a deal transaction with a leading US generic pharmaceutical...
GeneriCo, LLC Prevai
GeneriCo, LLC Prevails in Inter Partes Review of United States Patent 8,865,688
May 19, 2017 16:35 ET | GeneriCo, LLC
ST. LOUIS, May 19, 2017 (GLOBE NEWSWIRE) -- GeneriCo, LLC (GeneriCo), a global specialty generic drug company, today announced that the Patent Trial and Appeal Board (“PTAB”) of the U.S. Patent and...
Pharmaceuticals Vete
Pharmaceuticals Veteran George R. Stevenson Joins the GeneriCo Board of Directors
January 27, 2017 11:29 ET | GeneriCo, LLC
ST. LOUIS, Jan. 27, 2017 (GLOBE NEWSWIRE) -- GeneriCo, LLC (“GeneriCo”), a global generic specialty pharmaceutical company, is pleased to announce that George R. Stevenson has joined the Company’s...
GeneriCo Announces C
GeneriCo Announces Collaboration with Zhejiang Hisun to Launch Generic Pharmaceutical Products in the US
September 08, 2016 22:30 ET | GeneriCo, LLC
ST. LOUIS, Sept. 08, 2016 (GLOBE NEWSWIRE) -- GeneriCo, LLC, a global specialty generic pharmaceutical company, has announced the signing of a collaboration with Zhejiang Hisun Pharmaceutical Co,...
GeneriCo, LLC Inter
GeneriCo, LLC Inter Partes Review of United States Patent 8,865,688 Instituted
June 13, 2016 09:00 ET | GeneriCo, LLC
ST. LOUIS, June 13, 2016 (GLOBE NEWSWIRE) -- GeneriCo, LLC (“GeneriCo”), a global specialty generic drug company, today announced it has received a favorable institution decision for its petition...
GeneriCo, LLC Files
GeneriCo, LLC Files for Inter Partes Review of United States Patent 8,865,688
December 15, 2015 20:41 ET | GeneriCo, LLC
ST. LOUIS, Dec. 15, 2015 (GLOBE NEWSWIRE) -- GeneriCo, LLC (“GeneriCo”) today announced that it has recently filed a petition for Inter Partes Review (“IPR”) of United States Patent No. 8,865,688...